{"id":"tp-50501","type":"article-newspaper","title":"Myriad Genetics Raises 2026 Revenue Outlook Midpoint to $785 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50501","datePublished":"2026-11-07T02:04:37.000Z","dateModified":"2026-11-07T02:04:37.000Z","language":"en","abstract":"The company set a range of $780 million to $790 million as higher revenue per test partly offsets expected Prenatal Health softness.","section":"Business","references":[{"title":"agreement to sell its Prenatal Health testing business to Labcorp","url":"https://www.tokenpost.com/news/business/36029"}]}